Across TCGA pan-cancer cohorts, LINC01733 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC01733’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01733 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01733 is over-expressed in tumor, although a few such as UCEC and THCA show the opposite, repressed pattern.

HNSC, BRCA, and KIRP are the cancer types where LINC01733 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01733 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.010	.003	6	view →
BRCA	Female	II,III,IV	+0.008	.004	6	view →
KIRP	All	III,IV	+0.024	.038	3	view →
UCEC	All	All	−0.036	.028	2	view →
THCA	Female	All	−0.015	.006	2	view →
STAD	Male	IV	+0.035	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

Exploration

Same gene, other analysis: LINC01733 RNA expression & survival · all LINC01733 data types